BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31220287)

  • 1. Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.
    Gharzai LA; Green MD; Griffith KA; Else T; Mayo CS; Hesseltine E; Spratt DE; Ben-Josef E; Sabolch A; Miller BS; Worden F; Giordano TJ; Hammer GD; Jolly S
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3743-3750. PubMed ID: 31220287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma.
    Sabolch A; Else T; Griffith KA; Ben-Josef E; Williams A; Miller BS; Worden F; Hammer GD; Jolly S
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):252-9. PubMed ID: 25754631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.
    Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma.
    Habra MA; Ejaz S; Feng L; Das P; Deniz F; Grubbs EG; Phan A; Waguespack SG; Ayala-Ramirez M; Jimenez C; Perrier ND; Lee JE; Vassilopoulou-Sellin R
    J Clin Endocrinol Metab; 2013 Jan; 98(1):192-7. PubMed ID: 23150683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Radiation is Associated with Improved Survival for Select Patients with Non-metastatic Adrenocortical Carcinoma.
    Nelson DW; Chang SC; Bandera BC; Fischer TD; Wollman R; Goldfarb M
    Ann Surg Oncol; 2018 Jul; 25(7):2060-2066. PubMed ID: 29748889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant and definitive radiotherapy for adrenocortical carcinoma.
    Sabolch A; Feng M; Griffith K; Hammer G; Doherty G; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1477-84. PubMed ID: 20675074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.
    Else T; Williams AR; Sabolch A; Jolly S; Miller BS; Hammer GD
    J Clin Endocrinol Metab; 2014 Feb; 99(2):455-61. PubMed ID: 24302750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
    Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.
    Berruti A; Grisanti S; Pulzer A; Claps M; Daffara F; Loli P; Mannelli M; Boscaro M; Arvat E; Tiberio G; Hahner S; Zaggia B; Porpiglia F; Volante M; Fassnacht M; Terzolo M
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1358-1365. PubMed ID: 28324035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
    Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32449514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of adjuvant radiation therapy in localized adrenocortical carcinoma.
    Wu L; Chen J; Su T; Jiang L; Han Y; Zhang C; Zhou W; Jiang Y; Zhong X; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1308231. PubMed ID: 38260140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of radiotherapy in adrenocortical carcinoma.
    Ho J; Turkbey B; Edgerly M; Alimchandani M; Quezado M; Camphausen K; Fojo T; Kaushal A
    Cancer J; 2013; 19(4):288-94. PubMed ID: 23867507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis.
    Zhu J; Zheng Z; Shen J; Lian X; Miao Z; Shen J; Zhang F
    Radiat Oncol; 2020 May; 15(1):118. PubMed ID: 32448148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to radiation therapy in adrenocortical carcinoma.
    Hermsen IG; Groenen YE; Dercksen MW; Theuws J; Haak HR
    J Endocrinol Invest; 2010 Nov; 33(10):712-4. PubMed ID: 20220294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of Postoperative Radiotherapy for Patients With Nonmetastatic Adrenocortical Carcinoma: A Population-Based Analysis.
    Wu K; Liu X; Liu Z; Lu Y; Wang X; Li X
    J Natl Compr Canc Netw; 2021 Dec; 19(12):1425-1432. PubMed ID: 34902831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.
    Zhang F; Liu Z; Liang J; Liu S; Wu K; Zhang F; Zhou C; Lu Y; Zhu Y; Wang X
    BMC Cancer; 2021 Aug; 21(1):961. PubMed ID: 34445989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.
    Calabrese A; Basile V; Puglisi S; Perotti P; Pia A; Saba L; Berchialla P; Porpiglia F; Veltri A; Volante M; Reimondo G; Berruti A; Terzolo M
    Eur J Endocrinol; 2019 Jun; 180(6):387-396. PubMed ID: 30991359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy after surgical resection for adrenocortical carcinoma: A systematic review of observational studies and meta-analysis.
    Viani GA; Viana BS
    J Cancer Res Ther; 2019 Mar; 15(Supplement):S20-S26. PubMed ID: 30900615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
    Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical carcinoma: effect of hospital volume on patient outcome.
    Lombardi CP; Raffaelli M; Boniardi M; De Toma G; Marzano LA; Miccoli P; Minni F; Morino M; Pelizzo MR; Pietrabissa A; Renda A; Valeri A; De Crea C; Bellantone R
    Langenbecks Arch Surg; 2012 Feb; 397(2):201-7. PubMed ID: 22069043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.